Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05156268
Title A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

endometrial carcinoma

uterine carcinosarcoma

Therapies

Olaparib + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST